1 min read Business Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B | CBC News 3 years ago Pfizer Inc. said on Monday it would buy Canadian drug developer Trillium Therapeutics Inc. in a $2.26 billion deal to...